Cargando…
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT and the usefulness of the serum C-reactive protein...
Autores principales: | Wakasaki, Takahiro, Yasumatsu, Ryuji, Masuda, Muneyuki, Takeuchi, Toranoshin, Manako, Tomomi, Matsuo, Mioko, Jiromaru, Rina, Uchi, Ryutaro, Komune, Noritaka, Noda, Teppei, Nakagawa, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463840/ https://www.ncbi.nlm.nih.gov/pubmed/32824226 http://dx.doi.org/10.3390/cancers12082299 |
Ejemplares similares
-
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
por: Wakasaki, Takahiro, et al.
Publicado: (2022) -
Malignant perivascular epithelioid cell tumor mimicking jugular foramen schwannoma: A case report and literature review
por: Komune, Noritaka, et al.
Publicado: (2020) -
Cancer of the External Auditory Canal with Extensive Osteoradionecrosis of the Skull Base after Re-Irradiation with Particle Beams: A Case Report
por: Matsuo, Mioko, et al.
Publicado: (2021) -
Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options
por: Jiromaru, Rina, et al.
Publicado: (2022) -
Genetic landscape of external auditory canal squamous cell carcinoma
por: Sato, Kuniaki, et al.
Publicado: (2020)